- Home
- ANTX vs FGNX Comparison
ANTX vs FGNX Comparison
Compare ANTX & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- FGNX
- Stock Information
- Founded
- ANTX 2017
- FGNX 1932
- Country
- ANTX United States
- FGNX United States
- Employees
- ANTX N/A
- FGNX N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- FGNX Property-Casualty Insurers
- Sector
- ANTX Health Care
- FGNX Finance
- Exchange
- ANTX Nasdaq
- FGNX Nasdaq
- Market Cap
- ANTX 31.4M
- FGNX 25.2M
- IPO Year
- ANTX 2022
- FGNX N/A
- Fundamental
- Price
- ANTX $1.26
- FGNX $10.27
- Analyst Decision
- ANTX Buy
- FGNX
- Analyst Count
- ANTX 2
- FGNX 0
- Target Price
- ANTX $2.00
- FGNX N/A
- AVG Volume (30 Days)
- ANTX 84.9K
- FGNX 180.5K
- Earning Date
- ANTX 08-12-2025
- FGNX 08-07-2025
- Dividend Yield
- ANTX N/A
- FGNX N/A
- EPS Growth
- ANTX N/A
- FGNX N/A
- EPS
- ANTX N/A
- FGNX 2.41
- Revenue
- ANTX N/A
- FGNX $24,184,000.00
- Revenue This Year
- ANTX N/A
- FGNX N/A
- Revenue Next Year
- ANTX N/A
- FGNX N/A
- P/E Ratio
- ANTX N/A
- FGNX $5.08
- Revenue Growth
- ANTX N/A
- FGNX 24.03
- 52 Week Low
- ANTX $0.98
- FGNX $10.10
- 52 Week High
- ANTX $1.68
- FGNX $41.25
- Technical
- Relative Strength Index (RSI)
- ANTX 67.16
- FGNX N/A
- Support Level
- ANTX $1.09
- FGNX N/A
- Resistance Level
- ANTX $1.29
- FGNX N/A
- Average True Range (ATR)
- ANTX 0.06
- FGNX 0.00
- MACD
- ANTX 0.02
- FGNX 0.00
- Stochastic Oscillator
- ANTX 87.50
- FGNX 0.00
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.